Hillhouse Capital to pay $331m to up stake in Chinese pharma Asymchem

Hillhouse Capital to pay $331m to up stake in Chinese pharma Asymchem

17 February, 2020

Asymchem Laboratories Hillhouse Capital Management

Printed by Unregistered user on Sun, 08 Feb 2026 13:05:52 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Hillhouse-backed snacks retailer Bestore plans $70m Shanghai IPO

Hillhouse-backed electrical products maker Bull Group raises $511m in Shanghai IPO

Read more from Greater China

Editor’s Take: The Week That Was—Feb 2-7

China’s Capital Today ends evergreen structure, returns to closed-ended funds: Report